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Abstract
Hydroxyapatite and chitosan are widely used in biomedical applications due to
their biocompatibility and biodegradability. Various studies show that composites made
of hydroxyapatite and chitosan exhibit desirable properties for applications in bone tissue
engineering. When creating a composite it is important to understand the interfacial
chemistry and physical interactions between the composite materials. An understanding
of these properties gives more insight into the resulting structure of the composite on
multiple levels (nano- micro- macro). This structure affects the chemical, physical, and
mechanical properties of the material, thus analysis of these properties gives a better
understanding of how a material will perform when used in various applications. The
goal of this research project was to explore the chemical and physical interactions that
occur between hydroxyapatite nanoparticles (HANPs) and the polymer chitosan in a
novel nanocomposite.
In this project, composites of HANPs and chitosan were synthesized using
varying concentrations of the two materials. The composites were analyzed through
particle size analysis, Scanning Electron Microscopy (SEM), Dispersive X-ray
spectroscopy (EDX), Nuclear Magnetic Resonance spectroscopy (NMR), and X-ray
Diffraction (XRD). The results of the study showed mixtures of 10% chitosan and 90%
HANPs (dry weight fraction) produce composites with the smallest particle size. The
particle size of this composite was then further reduced through chemo-mechanical
processing to create a nanocomposite. NMR data suggests that chemical interactions
occur between the materials and from analysis of their chemical structures these
interactions are most likely hydrogen bonding and coordination bonds. XRD analysis
shows a phase change does not occur in the composite after mixing, however there are
some phase changes after chemo-mechanical processing.

Confidential

Acknowledgements
Special thanks to:
Dr. Ajay P. Malshe – for encouraging undergraduates to become involved with research
Dr. Anoop Samant- for continual guidance and support
Wenyang Zhang - for help with particle analysis equipment and XRD analysis
Mourad Benamara – for help in learning SEM imaging
Mike Hawkridge – for expertise in XRD imaging

Parts of this work were financially supported by a Student Undergraduate Research
Fellowship grant from the Arkansas Department of Higher Education. Any opinions,
findings, and conclusions or recommendations expressed in this material are those of
the author and do not necessarily reflect the views of the Arkansas Department of
Higher Education.
i

Confidential

ii

Confidential

Table of Contents
Acknowledgements.......................................................................................................................... i
Introduction .................................................................................................................................... 2
Methods .......................................................................................................................................... 6
Composite Preparation ............................................................................................................... 6
Chemo-Mechanical Processing ................................................................................................... 7
Results ............................................................................................................................................. 7
Particle Size Determination ........................................................................................................ 7
Energy Dispersion X-ray Spectroscopy (EDX)............................................................................ 13
Nuclear Magnetic Resonance Spectroscopy (NMR) ................................................................. 15
X-Ray Diffraction Spectroscopy (XRD) ...................................................................................... 17
Discussion...................................................................................................................................... 18
Conclusions ................................................................................................................................... 19
Future Directions .......................................................................................................................... 20
References .................................................................................................................................... 21

1

Confidential

Introduction
The prevalence of patients with bone loss and fracture from various diseases continues to
increase in the United States. Among these diseases is osteoporosis, which causes a decrease in
bone mineral density [1–3]. Several solutions to the problem of bone loss exist today, including
bone autografts and allografts, however both of these treatments have their own disadvantages.
Bone autograft complications include insufficient wound healing, donor pain, and insufficient
bone material to fill fractures and gaps. Allografts on the other hand pose threats of patient
immune reactions and transmissible diseases [4]. Another solution to the problem of bone loss is
bone implants made of hydroxyapatite, glass-ceramics, or titanium [5]. In the area of vertebrae
bone density loss, injectable polymer methyl methacrylate (PMMA) composites are most
common. These composites are normally used in vertebroplasty in which PMMA is injected into
a vertebra with decreased bone density or fracture. The use of PMMA in this application
however poses various problems. After injection, the polymer’s dense nature can lead to
subsequent vertebrae compression fractures. Other negative aspects include failure to adhere to
surrounding bone surfaces, high exothermic reaction temperature, and insufficient degradation in
the body [3].
In recent years mixtures of nanoparticles in different dispersion media have become a
common method for drug delivery and tissue repair. In general nanoparticles are preferred in
these applications when compared to microparticles because they have distinct properties that
can be tuned during synthesis. Nanoparticles also resemble the size of biological molecules (e.g.
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proteins, DNA, signal molecules) and structures (e.g. viruses and bacteria), which allows them to
better interact with the native, target tissues [6].
Due to the desirable properties of nanoparticles, the goal of this project was to create a
composite made of nanoparticles for use in bone tissue repair. This composite would be used in
patients by injecting it into areas of bone loss or bone fracture. After creating this composite, the
goal was to explore the chemical and physical interactions between the nanoparticles and the
dispersion medium. Understanding this interfacial chemistry between the materials gives insight
into the resulting nano- micro- macro structure, which affects the physical and chemical
properties of material. By understanding these properties, a better understanding is gained of
how the material will perform when used in various applications.
There are many kinds of nanoparticles used in different biomedical applications.
Examples can be found in Table 1 and of these materials, hydroxyapatite and silica are used in
bone tissue applications. Along with these are various materials used as dispersion media to
carry the nanoparticles inside the body (Table 2). All of these dispersion media however have
various drawbacks for this project.

Table 1. Nanoparticles for Biomedical Applications
Nanoparticle Material

Biomedical Application

Hydroxyapatite

Bone repair/growth [7]

Silica

Bone repair/growth [8]

Gold

Tumor targeting [9]

Albumin

Tumor targeting [10]

Glycol Chitosan

Low water soluble drugs [11]
3
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Table 2. Common Nanoparticle Dispersion Media
Dispersion Medium

Drawbacks

Methyl Methacrylate

Low osteoconductivity, cell attachment and proliferation [1,3]

Alginate Hydrogel

Preparation time more than 24 hours [12]

Carboxymethyl Chitin

Carboxymethyl Chitosan

Difficult to prepare from chitin; commercial sources not
economical [13]
Difficult to prepare from chitin and chitosan; commercial
sources not economical [14]

In recent years, hydroxyapatite and chitosan have become common materials used in the
area of bone tissue engineering. Composites made of these materials have proved to be more
promising for bone repair and replacement when compared to other materials and treatment
methods [4].
Hydroxyapatite [Ca10(PO4)6(OH)2] is a major inorganic component of the human body
[15,16]. It is known to be biocompatible, bioactive, and has been used successfully in various
biomedical applications [13,17–19]. As seen in Figure 1, hydroxyapatite has a hexagonal crystal
structure. For pure hydroxyapatite, the calcium phosphate ratio is 1.67 [20]. Pure hydroxyapatite
however has poor mechanical properties, including brittleness, and is difficult to mold into a
desired shape. Its direct implantation also results in displacement of the material from its
intended tissue [12,16]. Thus, hydroxyapatite by itself is a poor biomaterial, despite its positive
biological properties.
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Figure 1. Crystal Structure of Hydroxyapatite [21]

Chitosan is biocompatible, non-toxic, biorenewable, and biodegradable [22–24]. It is also
known to promote cell growth and has been used in numerous biomedical applications such as
wound dressings and drug delivery [14,24]. Chitosan is a linear, heteropolysaccharide consisting
of β-1,4-linked glucosamine and N-acetylglucosamine units (Fig. 2). This linkage results in a
rigid and unbranched structure. The crystalline structure and presence of hydroxyl groups allow
for both intra- and intermolecular hydrogen bonding [24]. In previous studies, chitosan has been
used as an adhesive to solve the problem of hydroxyapatite displacement and to allow for
molding of hydroxyapatite into a desired shape [23].

Figure 2. Primary Structure of Chitosan [24]
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Methods
In this project, chitosan was used as the dispersion medium for hydroxyapatite
nanoparticles (HANPs) to create a novel nanocomposite. Chemo-mechanical processing in the
form of ball-milling was used to make the final nanocomposite. Various chemical and physical
properties of the composite were analyzed. Chemical properties of the composites were explored
using energy dispersive X-ray spectroscopy (EDX) for elemental analysis and nuclear magnetic
resonance spectroscopy (NMR) for functional group analysis. Physical characterization included
particle size analysis using a particle analyzer and scanning electron microscopy (SEM), and
phase characterization was performed using X-ray diffraction spectroscopy (XRD).

Composite Preparation
HANPs were purchased from Nanoshel (Wilmington, Del.) and low molecular weight
chitosan powder was purchased from Sigma Aldrich (St. Louis, Mo.). Four composites were
prepared with varying fractions of HANPs and chitosan powder. Composites consisted of 10%,
30%, 50%, and 70% chitosan by weight and corresponding weight fraction of HANPs (Table 3).
Each sample was prepared by mixing chitosan powder with water and 2% acetic acid. HANPs
were then added and the solution was mixed for six hours at 37°C and 800rpm.
Table 3. Weight Fractions of Prepared Composites
Composite

Chitosan (%wt)

HANPs (%wt)

1

10

90

2

30

70

3

50

50

4

70

30
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Chemo-Mechanical Processing
The goal of the study was to create a novel nanocomposite between chitosan and HANPs.
Particle size analysis showed that none of the prepared composites consisted of particles within
the nanometer range, thus the particle size of the composite needed to be further reduced.
Because Composite 1 produced the smallest particle size, this fraction of materials was used for
further particle size reduction. In order to reduce the size of the particles, chemo-mechanical
processing in the form of ball-milling was performed on samples of Composite 1. A ceramic
zirconia vial and ceramic zirconia balls were used in combination with a ball-mill for processing.
Samples of Composite 1 were ball-milled for 36 hours to determine if particle size could be
further reduced.

Results
Particle Size Determination
Starting Materials
The particle size of HANPs and chitosan powder was analyzed using a laser diffraction
particle size distribution analyzer (Partica LA-950, Horiba, Houston, TX) and scanning electron
microscopy (SEM) (Fig. 3,4). Particle size for each sample was determined from SEM images
using ImageJ software.
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Figure 3. SEM of Hydroxyapatite Nanoparticles

Figure 4. SEM of Chitoan Powder

Mean particle size of chitosan powder was determined to be 218μm with particle
analyzer. Mean particle size of chitosan from SEM analysis was determined to be 204μm. Mean
particle size of HANPs was determined to be 275nm with particle analyzer. Mean particle size of
8
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HANPs from SEM analysis was determined to be 82.5nm. The inconsistency in measured data
between particle size analyzer and SEM images for HANPs is believed to be associated with
HANPs agglomeration in analysis with the particle analyzer. SEM images confirm that
individual HANPs particles are less than 100nm.
Composites
All four composites were analyzed through SEM (Fig. 5-8). Samples of each composite
were dried before SEM analysis and coated through gold sputtering. Particle size for each
composite was determined through SEM images using ImageJ software. Measurements were
repeated on three different samples for each of the four composites. Each of the three samples
was measured three times for a total of nine measurements for each composite (Table 4).

Figure 5. SEM Composite 1
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Figure 6. SEM Composite 2

Figure 7. SEM Composite 3
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Figure 8. SEM Composite 4

Table 4. Particle Size of Composites
Composite

Particle Size*

1

15.9μm

2

113μm

3

190μm

4

22.0μm
*Based on preliminary visual data

Particle size analysis showed that Composite 1 (90% HANPs, 10% chitosan) produced
the smallest particles, however none of the composites had consistent particle size within the
nanometer range.
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Chemo-Mechanical Processed Composites
Samples of Composite 1 were ball-milled for 36 hours to determine if particle size could
be further reduced. Average particle size was measured with a particle size analyzer. Results of
particle size analysis for three different samples after 36 hours of ball-milling can be found in
Table 5. SEM of Composite 1 after 36 hours of ball-milling can be found in Figure 9.
Table 5. Average Particle Size of Composite 1 after Chemo-Mechanical Processing
Composite 1
Sample
1

Initial Average
Particle Size
778 nm

Average Particle Size
After Processing
516 nm

2

661 nm

285 nm

3

536 nm

436 nm

Figure 9. SEM of Composite 1 after Chemo-Mechanical Processing
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Chemo-mechanical processing of samples through ball-milling successfully reduced the
particle size of the composite. SEM images of the ball-milled composite reveal that individual
particles are less than 100nm, however particles appear to be fused together.

Energy Dispersion X-ray Spectroscopy (EDX)
EDX was performed using the EDX function on a scanning electron microscope for each
of the four composites. Results of EDX analysis for samples of composites can be found in
Figures 10-13.

Figure 10. EDX of Composite 1

Figure 11. EDX of Composite 2
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Figure 12. EDX of Composite 3

Figure 13. EDX of Composite 4
EDX analysis of all composites showed areas of calcium, phosphorus, and oxygen. All
these elements are found in hydroxyapatite, however of these elements only oxygen is present in
chitosan. Further analysis needs to be done in the future to determine if carbon and nitrogen are
present in the samples and were undetected by EDX.
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Nuclear Magnetic Resonance Spectroscopy (NMR)
In order to determine the functional groups present in the composites, NMR spectroscopy
was performed on samples of each composite (Fig. 14-17).

Figure 14. NMR of Composite 1

Figure 15. NMR of Composite 2
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Figure 16. NMR of Composite 3

Figure 17. NMR of Composite 4
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NMR revealed hydroxyl groups in each composite, however only Composite 1 showed
the amine group from chitosan.

X-Ray Diffraction Spectroscopy (XRD)
To determine if phase changes occurred between the starting materials and composite,
powder x-ray diffraction was performed on samples of chitosan powder, HANPs, Composite 1,
and Composite 1 after 36 hours of ball-milling (Fig. 18).

Figure 18. XRD of chitosan powder, HANPs, Composite 1, and Composite 1 after 36 hours ball-milling

The major peaks measured for chitosan powder and HANPs, match peaks found in
previous studies [25,26]. Composite 1 retained a similar crystal structure to HANPs as the XRD
spectra for the two samples have nearly identical peaks. The (100) and (020) peaks found in
17
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chitosan powder are absent in both Composite 1 and Composite 1 after ball-milling. Both
Composite 1 and Composite 1 after ball-milling retained the (002) peak characteristic of HANPs
[26,27]. After ball-milling the (002) peak in Composite 1 showed increased intensity. Several
new peaks appeared in Composite 1 after ball-milling.

Discussion
Particle size analysis
Particle size analysis showed that the optimal fraction for making a chitosan-HANPs
nanocomposite is 10% chitosan powder and 90% HANPs (dry weight fraction). Though none of
the initial composites had particle sizes within the nanometer range, chemo-mechanical
processing successfully reduced the particle size to a desired range.
EDX
EDX analysis revealed that the surface of the composites was mostly composed of
calcium, phosphorus, and oxygen. These results may show that hydroxyapatite is the
predominant material on the surface of composite particles. Further testing of the processed
materials needs to be performed to understand if the composite consists of chitosan particles
coated in HANPs.
NMR
NMR data showed some chemical properties of the starting materials remained distinct in
the composite, including hydroxyl groups and some amine groups in Composite 1. The absence
of the amine group in Composites 2-4 could be explained by the potential coordination bond
18
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between the amine groups of chitosan and the Ca2+ ions of hydroxyapatite (Fig. 19). From the
structure of the two materials, the particles may also be held together by hydrogen bonding, but
further analysis is necessary to confirm this bonding.

Figure 19. Possible Coordination Bond between Hydroxyapatite and Chitosan [4]

XRD
XRD analysis revealed Composite 1 retained major crystal properties of HANPs both
before and after chemo-mechanical processing. Several new peaks appeared after processing.
Further studies are necessary to determine if these peaks represent new crystal structures,
increased intensity of existing structures, or contamination by the zirconia ceramic vial and balls.

Conclusions
It was determined through this study that the optimal fraction for making a chitosanHANPs nanocomposite is 10% chitosan powder and 90% HANPs. Through chemo-mechanical
processing the average particle size of this composite was reduced from 778nm to 285nm.
The outcomes of this project were a method for mixing chitosan powder and HANPs to
make a nanocomposite. Chemical analysis through EDX and NMR showed that some of the
chemical properties of the starting materials remained distinct in the composite, however there is
19
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some evidence of a coordination bond between the amine groups of chitosan and the Ca2+ ions of
hydroxyapatite. Analysis of composites through XRD revealed that Composite 1 retained the
major crystal properties of HANPs both before and after chemo-mechanical processing, however
several new peaks appeared after processing. More experiments must be conducted to confirm
whether these peaks are evidence of new crystal phases, intensification of existing phases, or
contamination from processing.

Future Directions
Sample Preparation
An ideal composite will be one in which chitosan particles and HANPs are evenly
dispersed. In order to create such a composite and one with even further reduced particle size, the
particle size of chitosan powder should be closer to that of HANPs. One way to achieve this
would be processing the chitosan powder through chemo-mechanical processing before mixing
with HANPs.
In vivo Studies
Samples of Composite 1 have been sent to the University of Arkansas for Medical
Sciences (UAMS) in Little Rock, Arkansas. Ernest Ferris, M.D., of the Department of
Radiology, will be conducting in vivo studies in rabbits with the composite to determine the
immune response and osseointegration of the composite.
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